IVF denied as not FDA-approved for this use by Kaiser Permanente?

Kaiser Permanente's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Kaiser Denied IVF as Not FDA-Approved — and How to Appeal

This denial reason typically does not apply to IVF as a core surgical and laboratory procedure, because IVF is a physician-performed medical service rather than a drug or device that requires FDA approval. When this classification appears on an IVF denial, it most often targets a specific adjunctive technology, add-on laboratory service, or pharmaceutical component of the cycle — for example, a particular culture medium, device, genetic testing platform, or a medication used in a non-FDA-labeled indication. Identifying exactly which component triggered the denial is the essential first step.

## Why This Denial Is Appealable

Even when a component lacks a specific FDA approval for infertility use, that does not automatically make its use inappropriate or non-covered. FDA approval governs drug and device marketing, not the practice of medicine. Physicians routinely use FDA-approved products in evidence-supported ways that are consistent with clinical guidelines but may not appear in the FDA label. Your plan's coverage policy — not FDA approval status alone — governs what is covered, and that policy can be challenged when applied inconsistently or contrary to accepted clinical practice.

## Federal Appeal Framework

Under ACA §2719 and ERISA §503:

• Internal appeal: Request the exact denial rationale in writing. File your appeal with documentation clarifying the regulatory status of the item denied and the clinical basis for its use.
• External review: Available after Kaiser upholds the denial internally. The external reviewer applies an independent medical standard and is not bound by Kaiser's internal classification. You generally have four months from final internal denial.
• Expedited review: Available when delay poses a significant health risk or where the treatment window is time-limited.

## Concrete Appeal Steps

1. Request the denial letter and identify the specific item Kaiser classified as not FDA-approved. 2. Confirm the actual regulatory status of that item — whether FDA-cleared, approved, or used in a supported off-label manner. 3. Ask your reproductive endocrinologist to document the clinical rationale for using that specific item and its support in current reproductive medicine guidelines. 4. Obtain Kaiser's coverage policy for investigational or off-label services and address each criterion in your appeal. 5. Attach professional society position statements or peer-reviewed literature supporting the clinical use.

## Documentation Checklist

• Denial letter with specific item identified
• Prescriber letter explaining clinical rationale and standard-of-care basis
• Regulatory status documentation for the item in question
• Relevant clinical guidelines or society position statements
• Chart notes supporting the clinical indication

## Criteria-Mapping Strategy

Obtain Kaiser's written policy definition for "not FDA-approved" coverage exclusions. Map each element of that definition against the documentation your physician provides — particularly any criteria that allow coverage for off-label use supported by compendia or peer-reviewed literature. Addressing every element prevents reviewers from denying on a criterion you did not anticipate.